Inactive Instrument

News Taiwan Liposome Company, Ltd. Nasdaq

Equities

TLC

US8740381020

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Endo Ventures Limited Executes Agreement with Taiwan Liposome Company, Ltd. to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain	13/06/22	CI
TLC BioSciences Announces Publication of Tlc599 Phase Ii Results in Arthritis Research & Therapy	07/03/22	CI
Taiwan Liposome : Filings with the Taipei Exchange’s Market Observation Post System, dated October 8, 2021 - Form 6-K	08/10/21	PU
Woods Investment Company, Ltd. completed the acquisition of Taiwan Liposome Company, Ltd. from a group of sellers.	07/10/21	CI
Taiwan Liposome Company, Ltd.(NasdaqGM:TLC) dropped from NASDAQ Composite Index	29/09/21	CI
Taiwan Liposome : TLC to Present at Upcoming Virtual Investor Conferences	09/09/21	PU
Taiwan Liposome : TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares (Form 6-K)	08/09/21	PU
Taiwan Liposome : to Voluntary Delist From Nasdaq	08/09/21	MT
Taiwan Liposome : ANNUAL GENERAL MEETING MINUTES (Form 6-K)	27/08/21	PU
Taiwan Liposome : 2021 First EGM Minutes	26/08/21	PU
Taiwan Liposome : 2021 AGM Minutes	26/08/21	PU
Taiwan Liposome : 2021 Q2 Consolidated Financial Statements	16/08/21	PU
Taiwan Liposome : TLC Reports Second Quarter 2021 Financial Results and Provides Business Update (Form 6-K)	12/08/21	PU
Taiwan Liposome : TLC Reports Second Quarter 2021 Financial Results and Provides Business Update	12/08/21	PU
Taiwan Liposome : In case of any discrepancy between the English and the Chinese version, the Chinese version shall prevail (Form 6-K)	04/08/21	PU
Taiwan Liposome : 1st Amendment to the Share Swap Agreement	04/08/21	PU
Taiwan Liposome : Handbook for First Extraordinary General Meeting of 2021 (international shareholder other than ADS holders)	04/08/21	PU
Taiwan Liposome : 2021 EGM Notice	04/08/21	PU
Taiwan Liposome : 2021 EGM Agenda	23/07/21	PU
Type of merger and acquisition (e.g. merger, spin-off, acquisition, or share transfer): Share Swap (Form 6-K)	22/07/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Taiwan Liposome Company, Ltd. Nasdaq

Equities

TLC

US8740381020

Summary

Filters